EISSN 2980-1478

INDEXED IN WEB OF SCIENCE AND SCOPUS INDEXED IN PUBMED CENTRAL

Urology Research & Practice

50 218 2024

HIGHLY CITED ARTICLES

Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study

By: Shah et al.

What do urologists need to know: Diagnosis, treatment, and follow-up during COVID-19 pandemic

By: Ho et al.

Thulium fiber laser: The new kid on the block

By: Schembri et al.

Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer

By: Danarto et al.

The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades

By: Gamage et al.

Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsy

By: Murray et al.

Problems and solutions of stent biofilm and encrustations: A review of literatüre

By: Khoddami et al.

First case of retroperitoneal hematoma in COVID-19

By: Scialpi et al.

Holmium laser enucleation of the prostate for the treatment of size-independent BPH: A single-center experience of 600 cases

By: Yalçın et al.

Transperineal prostate biopsy: The modern gold standard to prostate cancer diagnosis

By: By: Ortner et al.

Letter to the Editor

Fosfomycin as a promising alternative to treat urinary tract infection due to multidrug resistant uropathogens

Drisya Udayan ¹ , Sadia Khan ¹ , Unnimaya Pullanhi ¹ , Anil Kumar ¹

Author Affiliation(s)

1.

Department of Microbiology, Amrita Institute of Medical Sciences,Amrita Vishwa Vidyapeetham, Kochi, Kerala, India

Urol Res Pract 2018; 44: 515-515

DOI: 10.5152/tud.2018.55889

Read: 1141 Downloads: 419 Published: 25 July 2019

Volume 44, Issue 6, November 2018

Previous Article

Abstract

Cite this article as: Udayan D, Khan S, Pullanhi U, Kumar A. Fosfomycin as a promising alternative to treat urinary tract infection due to multidrug resistant uropathogens. Turk J Urol 2018; 44(6): 515.

Files